Privia Health price target raised to $21 from $19 at Barclays
The Fly

Privia Health price target raised to $21 from $19 at Barclays

Barclays analyst Andrew Mok raised the firm’s price target on Privia Health (PRVA) to $21 from $19 and keeps an Equal Weight rating on the shares post the Q3 report. Privia showed steady progress with modest outperformance in multiple books of business enabling a free cash flow raise, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App